Entropy Neurodynamics LimitedASX: ENP

Quarterly Activities Report and Appendix 4C

· Issued by Entropy Neurodynamics Limited via ASX

Filed with ASX ·

ASX Announcement ASX : ENP 28 October 2026 Quarterly Activities Report & Appendix 4C: September 2026 • TRP-8803 Phase 2 Binge Eating Disorder (BED) study delivers highly encouraging clinical results • Results included 100% of BED patients achieving clinically meaningful improvement and 50%...

View Attachment

6ix is reading this filing.

Entropy Neurodynamics Limited on 6ix

Story so far

Earlier from Entropy Neurodynamics

All Entropy Neurodynamics news releases